Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
metoprolol + carvedilol
- Development stage
- Unknown
- Lead developer
- Roche
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This entry refers to a comparative clinical study of metoprolol and carvedilol, conducted by Bispebjerg Hospital, focusing on patients with chronic heart failure and type 2 diabetes mellitus. Metoprolol is a cardioselective beta-1 adrenergic receptor antagonist, whereas carvedilol is a non-selective beta-blocker that also exhibits alpha-1 adrenergic receptor antagonism. The study (NCT00447512) evaluated the effects of these two beta-blockers on endothelial function and insulin-stimulated endothelial function. Carvedilol is hypothesized to have a more favorable effect on these parameters compared to metoprolol due to its vasodilatory and antioxidant properties, which may be particularly beneficial in patients with metabolic comorbidities like type 2 diabetes.
- Other names
- metoprololcarvedilol
02
Targets
ADRA1A (α1A)ADRB1 (β1)ADRB2 (β2)
Beyond the preview
Go deeper on metoprolol + carvedilol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on metoprolol + carvedilol.